Sanofi India share price has zoomed 5% and is presently trading at Rs 7,539.6.
Meanwhile, the BSE HEALTHCARE index is at 37,154.6 (up 0.1%).
Among the top gainers in the BSE HEALTHCARE index today are Biocon (up 2.8%) and Torrent Pharma (up 2.8%).
GLAND PHARMA (down 1.3%) and SUN PHARMA ADV. RES. (down 1.2%) are among the top losers today.
Over the last one year, Sanofi India has moved up from Rs 6,892.0 to Rs 7,539.6, registering a gain of Rs 647.6 (up 9.4%).
On the other hand, the BSE HEALTHCARE index has moved up from 24,514.7 to 37,154.6, registering a gain of 51.6% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were Cadila Healthcare (up 102.9%), Jubilant Pharmova (up 97.3%) and POLY MEDICURE (up 96.4%).
Must See: These Segments are Witnessing Incredible Growth with Modi's Push
The BSE Sensex is at 77,415.2 (up 0.1%).
The top gainers among the BSE Sensex today are Indusind Bank (up 2.3%) and ICICI Bank (up 1.7%). The most traded stocks in the BSE Sensex are Tata Steel and ICICI Bank.
In the meantime, NSE Nifty is at 23,588.6 (up 0.1%). Indusind Bank and ICICI Bank are among the top gainers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 63,228.5 to 77,415.2, registering a gain of 14,186.7 points (up 22.4%).
Sanofi India net profit fell 28.3% YoY to Rs 1,366 million for the quarter ended March 2024, compared to a profit of Rs 1,904 million a year ago. Net sales declined 0.6% to Rs 7,324 million during the period as against Rs 7,365 million in January-March 2023.
For the year ended December 2023, Sanofi India reported 2.9% decrease in net profit to Rs 6,029 million compared to net profit of Rs 6,206 million during FY22. Revenue of the company grew 2.9% to Rs 28,511 million during FY23.
The current Price to earnings ratio of Sanofi India, based on rolling 12 month earnings, stands at 31.6.
Equitymaster requests your view! Post a comment on "Sanofi India Gains 5%; BSE HEALTHCARE Index Up 0.1%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!